ursolic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, B; Guan, P; Han, L; Hu, C; Huang, X; Li, G; Li, L; Mu, Y; Wang, Z; Wu, W; Yu, H | 1 |
| Castro, MM; Duarte, IF; Duarte, MF; Guerra, ÂR; Oliveira, H; Paulino, AF | 1 |
| Chen, C; Chen, H; Chen, X; Li, W; Liu, R; Nie, M; Tian, Y; Zhang, H | 1 |
| Kalafatis, M; Manouchehri, JM | 1 |
4 other study(ies) available for ursolic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Discovery of Anti-TNBC Agents Targeting PTP1B: Total Synthesis, Structure-Activity Relationship,
Topics: Antineoplastic Agents; Apoptosis; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; G1 Phase Cell Cycle Checkpoints; Humans; MCF-7 Cells; Mitochondria; Molecular Targeted Therapy; Phenols; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Resting Phase, Cell Cycle; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2021 |
Triple Negative Breast Cancer and Breast Epithelial Cells Differentially Reprogram Glucose and Lipid Metabolism upon Treatment with Triterpenic Acids.
Topics: Betulinic Acid; Breast; Cell Cycle; Cell Line, Tumor; Cell Survival; Citric Acid Cycle; Epithelial Cells; Female; Glucose; Glycolysis; Hexosamines; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Metabolome; Metabolomics; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms; Triterpenes; Ursolic Acid | 2020 |
Ursolic acid derivative FZU-03,010 inhibits STAT3 and induces cell cycle arrest and apoptosis in renal and breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Female; G1 Phase Cell Cycle Checkpoints; Humans; Liver Neoplasms; Molecular Structure; Piperazines; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Triterpenes; Ursolic Acid | 2017 |
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer.
Topics: Cell Survival; Cells, Cultured; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Recombinant Proteins; TNF-Related Apoptosis-Inducing Ligand; Triple Negative Breast Neoplasms; Triterpenes; Ursolic Acid | 2018 |